Cure51, a TechBio company in Paris, is innovating cancer research by assembling a global database of over 1,500 cancer survivors from 42 countries. This platform allows for unique data analysis and sample sequencing. Their primary focus is on aggressive cancers, expanding future research to other diseases. Inspired by Rosalind Franklin, Cure51 seeks to identify survival mechanisms in exceptional cases, aspiring to transform cancer into a manageable condition, thereby honoring Franklin's legacy of groundbreaking contributions to molecular biology and medicine.
We named our Techbio startup Cure51 after Rosalind Franklin, whose works and discoveries were game-changing for modern medicine as we know it today.
We are seeking to unlock the biological mechanisms responsible for exceptional cancer survivors patients and through this, we want to make cancer a disease of the past.
Collection
[
|
...
]